Collectively, our work identified the OTUD1-PRDX1-mitochondrial axis as a key regulatory pathway in osteoclastogenesis, suggesting novel therapeutic opportunities for bone disorders through targeted modulation of this axis. This evidence concerns the gene OTUD1 and bone disorder.